20/Happy in 2020

Financtial Interest Index

Financial Interest Index

As a provider accredited by the Accreditation Council for
Continuing Medical Education, ASCRS must ensure balance, independence,
objectivity, and scientific rigor in all it’s individually or jointly provided
activities.

All individuals participating in an activity designated for
CME credit must disclose any financial interest or relationship with a company
that produces, markets, resells, or distributes ophthalmic
products/devices/drugs or services used on or by patients that are discussed in
an educational presentation or lack thereof. Financial interest can include
such things as grants or research support, consultant, stockholder, member of
speaker’s bureau, et. Relationships held by a spouse or a partner must also be
disclosed.

The intent of this disclosure is not to disqualify anyone
from participating, but to provide the program committee with information so
they can design and implement a balanced, independent and scientific
educational activity. The Financial Interest Index provides information to learners,
so they can make their own judgement regarding the interest or relationship and
the materials presented. A complete listing of relationships disclosed, and
their corresponding codes below.

Category	Code	Specific Financial Interest
Product	P	I earn royalty or derive other financial gain from an ophthalmic product or service
Investor	R	I have an investment interest in a company that produces, markets, resells, or distributes ophthalmic products/devices/drugs or services related to patient clinical care
Consultant	A	I receive a retainer, ad hoc fees, or other consulting income from a company that produces, markets or distributes ophthalmic products/devices/drugs or services related to patient clinical care.
	B	I am a member of the speakers' bureau of a company that produces, markets, resells, or distributes ophthalmic products/devices/drugs or services related to patient clinical care.
Practice Management Consultant	C	I provide practice management or marketing consulting services to ophthalmic practices.
Research	D	My research is fully or partially funded by a company that produces, markets, resells, or distributes ophthalmic produces/devices/drugs or services related to patient clinical care.
Travel	E	My travel expenses have been reimbursed, paid in full or subsidized by a company that produces, markets, resells or distributes ophthalmic products/devices/drugs or services related to patient clinical care.
Employee*	Y	I am a full-time employee of a company that produces, markets, resells, or distributes ophthalmic products/devices/drugs or services related to patient clinical care.
	Z	I am a part-time employee of a company that produces, markets , resells or distributes ophthalmic products/devices/drugs or services related to patient clinical care.
Spouse/Partner	S	My spouse or partner has a financial relationship with a company that produces, markets, resells or distributes ophthalmic products/devices/drugs or services related to patients clinical care, encompassing royalties, investment, consulting/speaker's bureau, research grants, travel reimbursement or employment.

Program Planning Committee

David Chang, MD Carl Zeiss, A; Eyenovia, R; ForSight Vision 6, R, A; iDrops, R, A; iVantis, R, A; J&J Vision, A; Mynosys, R, A; Perfect Lens, A; Presbyopia Therapies, R; Rx Sight, R, A; Slack, P; Surface, R; Versant Ventures, R; Viewpoint, R, A; Visionary Ventures II, R

Kendall Donaldson, MD Alcon, A; Allergan, A; Bausch and Lomb, A; Biotissue, A; Eyevance, A; Kala, A; Novartis, A; Omeros, A; SUN, A; Zeiss, A

Sumit “Sam” Garg, MD Aerie, A; Allergan, A; CorneaGen, A; Glaukos/Avedro, A; Johnson&Johnson, A, B; Kala, A; LensGen, A; Novartis, A, B; OcuTrx, R; Verana Health, A; VisionCare, A; Zeiss, A

Kevin Miller, MD Alcon Laboratorues, A, D; Johnson & Johnson Vision, A; Zeiss, A

Vance Thompson, MD Acufocus, R, A, D; Alcon, A, D; Allergan, A, D; Allotex, R, A; Avellino, R, A; Bausch and Lomb, A, D; BRIM Biotechnology, Inc, A; Carl Zeiss Meditec, A, D; Conjtac, R, A; CSO, A; Equinox, R, A, D; Euclid Systems, R, A; Expert Opinion, R, A; eyeBrain Medical Inc, R, A; Eyedetec, R, A; EyeGate Pharmaceutical, R, A, D; Glaukos, R, A; Healthe, R, A; Imprimis, A; iVeena, R, A; Johnson and Johnson, A, D; Melt Pharmaceuticals, R, A; Mynosys, R, A, D; Novaliq, A; Ocular Innovations, R, A; OneFocus, A; OPHTEC, A; Ora, A, D; Oyster Point Pharmaceutical, R, A; Percept, R, A; Precision Lens, A; ReFocus, A; RxSight, R, A, D; SightSciences, R, A, D; Stuart Therapeutics, R, A; Tarsus Rx, R, A; TearClear, R, A; ThruFocus, A; Treehouse Health, R, A; Veracity, R, A; Viewpoint Therapeutics, A; Visant, R, A; Visiometrics, A; Vivior AG, R, A

Module 1

Graham Barrett, MD Alcon, P, A; Bausch & Lomb, P; Carl Zeiss, P, A; Haag-Streit, P; Movu, P; Nidek, P; Oculos, P; Tomei, P; Topcon, P; Veracity, P

Oliver Findl, MD Alcon, A; Carl Zeiss Meditec AG, A; Johnson & Johnson, A; Merck, A

Sumit "Sam" Garg, MDAerie, A; Allergan, A; CorneaGen, A; Glaukos/Avedro, A; Johnson&Johnson, A, B; Kala, A; LensGen, A; Novartis, A, B; OcuTrx, R; Verana Health, A; VisionCare, A; Zeiss, A

Warren Hill, MD Alcon, A; Carl Zeiss Digital Innovations, A; Haag-Streit, P, A, D; LensAR, B; Omega Ophthalmics, R; Optos, B

Doug Koch, MD Alcon, A; CapsuLASER, R; Carl Zeiss Meditec, A; Ivantis, R; Johnson & Johnson Vision, A; Perfect Lens, A; Vivior, R

Robert Osher, MD Bausch + Lomb, A; BVI, A; EyePoint, A; MST, A; Omeros, A; SLACK, A; VJCRGS, R, Z; Zeiss, A

John Rubenstein, MD Alcon, A, B

Mitchell Weiker, MD Alcon Laboratories, Inc, A; Avellino Labs, Inc, A; Ziemer Ophthalmic Systems, Inc, A

Sonia Yoo, MD Avedro, A, D; Avellino Labs, A, D; Carl Zeiss Meditec, A; Dompe, A; Resolve Ophthalmics, P, D; Senju, D

Module 2

John Berdahl, MD Alcon, A, D, E; Allergan, D, E; Aurea Medical, A; Avedro, A, D, E; Bausch and Lomb, A, D, E; CorneaGen, A, D, E; Dakota Lions Eye Bank, A, E; Equinox, R, A, D, E; Expert Opinion, R, A, E; Glaukos, R, A, D, E; Gore, A; Imprimis, P, A; iRenix, A; Johnson and Johnson, A; Kala, A; Kedalion, A; MELT Pharmaceuticals, A, E; MicroOptix, A; New World Medical, A; Ocular Surgical Data, R, A; Ocular Theraputix, A; Omega Ophthalmic, R, A; Orasis, A; Oyster Point, A; RxSight, A, D; Surface, R, A; Tarsus, A; Tear Clear, A; Vance Thompson Vision, R, A, D, E, Y; Verana Health, R; ViaLase, A; Visionary Ventures, A; Vittamed, A; Zeiss, R, A

Daniel Chang, MD AcuFocus, D, E; Allergan, A, D, E; Carl Zeiss Meditec, A, B, E; Johnson & Johnson Vision, A, B, D, E; Mynosys Cellular Devices, A, D; Omega Ophthalmics, R, A

Kendall Donaldson, MD, MS Alcon, A; Allergan, A; Bausch and Lomb, A; Biotissue, A; Eyevance, A; Kala, A; Novartis, A; Omeros, A; SUN, A; Zeiss, A

Jack Holladay, MD Acufocus, R, A; Alcon, A; ArcScan, R, A; J&J, A; M&S Technologies, P, A; Oculus, A; RXSight, R, A; Visiometrics, P, A; Zeiss, P, A

Terry Kim, MD Aerie Pharmaceuticals, A; Alcon, A; Allergan, A; Avedro, A; Avellino Labs, R, A; Bausch & Lomb, A; Blephex, A; CorneaGen, R, A; Dompe, A; Eyenovia, R, A; Johnson & Johnson, A; Kala Pharmaceuticals, R, A; NovaBay Pharmaceuticals, R, A; Novartis, A; Ocular Therapeutix, R, A; Omeros, R, A; Presbyopia Therapies, R, A; Shire, A; Sight Sciences, A; Simple Contacts, R, A; Surface, A; Zeiss, A

Thomas Kohnen, MD Allergan, B; Avedro, C, D; Bausch & Lomb, B; Carl Zeiss, C, D; Dompé, B; Geuder, B; Hoya, D; Johnson & Johnson, C, D; Med Update, B; Merck KGaA, C; Novartis/Alcon, A, B, C, D; Oculentis, C, D; Oculus, C, D; Presbia, C, D; Rayner, C; Santen, C; Schwind, C, D; Staar, C; Tear Lab, B, C; Thea, C; Thieme, C; Zeiss, B, C; Ziemer, C

Bryan Lee, MD Acufocus, D; Aerie, A; Alcon, E; Katena, A; New World Medical, A; Zeiss, D

Francis Mah, MD Aerie, A; Akros Pharma, A; Alcon, A; Allergan, A, D; Avedro, A; Avellino Group, A; B & L, A, B; BlephEx, A; Dompe, A, B; Eyenovia, A; EyePoint, A; EyeVance, A; Glaucos, A; Ivantis, A; Iview, A, D; j & j vision, A, B, D; Kala, A, B; Nevakar, A; Novartis, A, B; NuSight, A; Ocular Science, R, A, D; Ocular Therapeutix, A, D; Okogen, R, A; Omeros, A; PMN, A; PolyActiva, A; RxSight, A; Shire/Takeda, A, B; SightSciences, A; Sun Pharma, A, B; Sydnexis, R, A; TearLab, A

Module 3

Steve Charles, MD Alcon, A

Steve Dell, MD Advanced Tear Diagnostics, A; Allergan, A; Bausch and Lomb, A; Johnson & Johnson, A; Lumenis, A; Optical Express, A; Presbyopia Therapies, R, A; Tracey Technologies, R, A

Preeya Gupta, MD Alcon, A; Allergan, A; BioTissue, A; J & J Vision, A; Novartis, A; Novartis, A; Zeiss, A

Edward Holland, MD Aerie, Akros, Avedro, Azura, BioTissue, BlephEx, BRIM biotech, Claris,Corneat,CorneaGen,Dompe,EyePoint,Glaukos,Hanall, Hovione,IanTECH,Imprimis Pharma,Invirsa,Johnson & Johnson Vision Care,Kala Pharmaceuticals, Katena, KeraKlear, Licrieye, B; KeraKlear, Mati Pharm, Novartis Pharm, Omeros, Senju Pharm, D; Mati Pharmaceuticals,Merck KGgA,MG Thera,Mintz,Nanowafer, Inc,Novaliq,Novartis NIBR,Novartis Pharmaceuticals,Novartis Surgical,Ocunexus,Ocuphire,Omeros,Ophthotech,OysterPoint,Precise Bio, B; Prometic, ReGenTree, LLC, Retear,Senju,Shire,Sight Sciences,SightLife,Silktech,Slack,Stuart Therapeutics,Takeda Coordination,Tarsus,Tearfilm Innovations,TearLab,TissueTech,Topivert Pharma Limited,Vomaris, WL Gore and Associates, Zeiss, B

John Hovanesian, MD MDbackline, Inc, R

Yuri McKee, MD Ivantis, D; LensAR, A; Zeiss, A

Nathan Radcliffe, MD Aerie, A, B; Alcon, A, B; Alimera, A, B; Allergan, A, B; Aurea, A, B; B + L, A, B; BVI, A, B; Carl Zeiss Meditec, B; CATS, LLC, A; Equinox, A, B; Equinox, R, A; Eyenovia, A, B; Eyepoint, A, B; Glaukos, A, B; Iridex, B, C; Ivantis, A, B; Lumenis, A, B; New World Medical, A, B; Novartis, A, B; Omeros, A; Reichert, A, B; Shire, A, B; Sight Science, A, B; SpyGlass, A; Thea, A

Neda Shamie, MD Alcon, A, B; Allergan, A, B; Amo, A, B; Avedro, A, B; Corneagen, A; Johnson & johnson, A, B; RX Sight, A, B

William Trattler, MD Alcon, A; Allergan, A, B; ArScan, R; Avedro, R, A; Bausch and Lomb, A; CXLO, R; Eyevance, A, B; Guardian, R; Imprimis, A; Intelligent Diagnostic s, R; Johnson and Johnson, R, A; Lensar, R, A, B; Novartis, A, B; Ocular Therapeutix, A; Oculus, A, B; Omeros, A, B; Orca, A; RxSight, R; Sight Sciences, A, B, D; Sun, A, B; Zeiss, P, A

Module 4

Rosa Brage0Mele, MD Alcon, A; J&J, A; LensGen, A; Zeiss, A

David, Chang, MD Carl Zeiss, A; Eyenovia, R; ForSight Vision 6, R, A; iDrops, R, A; iVantis, R, A; J&J Vision, A; Mynosys, R, A; Perfect Lens, A; Presbyopia Therapies, R; Rx Sight, R, A; Slack, P; Surface, R; Versant Ventures, R; Viewpoint, R, A; Visionary Ventures II, R

Arthur Cummings, MD Alcon, A, B, D; Allotex, D; Scope, A, D; TearClear, A; Vivior, R, D; WaveLight, A, B, D; Wellington Eye Clinic, E

Mitchell Jackson, MD ACE Vision Group, R; Allergan, B; Arcscan, R; Avellino, B; Bausch & Lomb, B; Calhoun Vision, R; Eyepoint Pharmaceuticals, B; Eyevance Pharmaceuticals, R, B; Healthe, R; Johnson & Johnson, B; Kala, B; Lensar, B; Lenticular Research Group, R; Novartis, B; Ocular Therapeutix, B; Omeros, B; Paragon Bioteck, R, B; Pogotec, R; RPS, R; Sun Pharmacueticals, B; Tear Lab, B

Stephen Slade, MD Alcon, B; Corneagen, R; Intratus, A; J&J, A; RXSIGHT, R, A; Zeiss, A

Dee Stephenson, MD Alcon, A, B; Atia Vision, Inc, A; baush & Lomb, A, B, D; Bruder Healthcare Company, B; Cassini USA, A, B; Eyepoint Pharmaceuticals, B; Eyevance Pharmaceuticals, B; Guardian HealthCare Sciences, A, B; Kala Pharmaceuticals, A, B; LENSAR, Inc, A, B; Ocular Therapeutix, Inc, A, B, D; Omeros, A, B; Sun Ophthalmics, A, B; Zeiss, A, B

Richard Tipperman, MD Alcon Laboratories, A; Diopsys Incorporated, B

William Wiley, MD Alcon, A; Allergan, A; CorneaGen, R, A; Equinox, R; Imprimis, P; Johnson and Johnson, A; RxSight, R, B; Zeiss, A

Module 5

Patti Barkey ALCON, A; ALLERGAN, B; EyePoint, B; J&J, B; Ocular Therapeutix, B; Quidell, B; TearLab, B

Kevin Cocoran, MD Corcoran Consulting Group, C

John Doane, MD Presbyopia Therapies, R, A; RxSight, D; Zeiss, A, D

Michael Dobkowski Glacial Multimedia, C

Alice Epitropoulos, MD No Relevant Financial Interests

Robert Maloney, MD Johnson and Johnson, A, D; Percept, R, A; Presbia, A; RxSight, R, A; Stroma Medical, R

Cathleen McCabe, MD Alcon, A, B, D; Allergan, A, B, D; Bausch and Lomb, A, B, D; EyePoint, A, B; Glaukos, A, B, D; Ivantis, A, B, D; Johnson & Johnson Vision, A, D; Novartis, A, B, D; Ocular Innovations, A; Ocular Therapeutix, A, B; Omeros, A, B; Sight Sciences, A; Sun Pharmaceuticals, A, D; Zeiss, A

Kerry Solomon, MD ALCON, A, B, C, D, E; AQUESYS, R, A; CLARVISTA, A; GLAUKOS, R, A; ICON BIOSCIENCES, D; IMPRIMIS, D; INTEGRITY DIGITAL SOLUTIONS, R, A; JOHNSON AND JOHNSON VISION, D; LENSTEC, D; MATI THERAPEUTICS, R; OCTANE VISIONARY VC FUND, R; OCUHUB, R; OMEROS CORP, R; POGOTEC, R; PRN, R, A; TEARLAB, R; TEARSCIENCE, D; VERACITY INNOVATIVE, R; VERSUANT, R; ZEISS, A, B

Module 6

Ike Ahmed, MD Aequus, B; Aerie Pharmaceutical, B, D; Akorn, B; Alcon, B, D; Arcscan, B; Bausch Health, B; Beaver Visitec, B; Beyeonics, B; Camras Vision, B, D; Carl Zeiss Mediteci, B; CorNeat Vision, B; ELT Sight, B; Elutimed, B; Equinox, B; Genentech, B; Glaukos, B, D; Gore, B; InjectSense, B; iSTART Medical, B, D; Ivantis, B, D; J & J Vision, B, D; MicroOptx, B; MST Surgical, B; Mundi Pharma, B; New world medical, B; Ocular instrument, B; Ocular therapeutix, B; Omega Ophthalmics, B; PolyActiva, B; Sanoculis, B; Santen, B, D; Science based health, B; Sight Sciences, B, D; Stroma, B; ViaLase, B; Vizzario, B

Deepinder Dhaliwal, MD Avedro, A, D; CorneaGen, B; Johnson & Johnson, A; Novaliq, A; noveome, D; Ocular therapeutix, B; Shire/Novartis, B; Staar Surgical, B; Trefoil, A

Eric Donnenfeld, MD Alcon, A, B; Allergan, A, B; Bausch & Lomb, A, B; Eyepoint, R, A, B; Glaukos, A, B, D; Johnson & Johnson, A; LensGen, A; mati, R, A, B, D; Ocular Therapeutix, A, B, D; Zeiss, A, B

Nicole Fram, MD AcuFocus, Inc, D; Aerie Pharmaceuticals, Inc, A; Alcon Laboratories, Inc, A, B, D; Allergan, A, D; Bausch and Lomb, B; CorneaGen, R, A; Dompé, B; Johnson & Johnson Vision, A, B; Novartis Pharma, B; Ocular Science, R, A; Shire, B; Sun Pharmaceutical, B; W.L. Gore, A; Zeiss, C

Richard Hoffman, MD Alcon Laboratories, A; Microsurgical Technology, A

Jay Pepose Acufocus, R, A; Allergan, A; Bausch + Lomb, A; Johnson & Johnson Vision, A; MG Therapeutics, R; Novartis, A; Ocunexis, A; Ocuphire, A; Okogen, A; Stuart Pharmaceuticals, A; Sun Pharma, A, B; TearLab, A

Steve Safran, MD No Relevant Financial Interests

John Vukich, MD AcuFocus, A, D; Avedro, B; Clerio, A; Johnson and Johnson, B, D; STAAR Surgical, A; Zeiss, B

Elizabeth Yeu, MD Alcon, D; Alcon, A; Allergan, D; Allergan, A; ArcScan, R; Avedro, A; Baush & Lomb, D; Baush & Lomb, A; BioTissue, D; BioTissue, A; Bruder, A; BVI, A; Carl Zeiss, A; CorneaGen, R; CorneaGen, A; Expert Opinion, A; EyePoint Pharm., A; Glaukos, A; iOptics, D; iOptics, A; J&J VIsion, A; Kala Pharm., D; Kala Pharm., A; LENSAR, A; Merck, A; Modernizing Medicine, R; Mynosys, A; Novartis, A; Ocular Science, R; Ocular Science, A; Ocular Therapeutix, A; OcuSoft, A; Omeros, A; Oyster Point Phar., A; Science Based Health, A; Shire, A; Strathespey Crown, R; Sun Pharm., A; TearLab Corp., A

Module 7

Zaina Al-Mohtaseb, MD Alcon, A; Allergan, B; Bausch and Lomb, A; Cornea Gen, A; J&J, A; Ocular Therapeutix, A; Zeiss, A

Richard Lindstrom, MD AcuFocus, Inc,, R, A; Advanced Refractive Technologies, A; Allegro, R, A; Alphaeon, R, A; Aquesys, R; Argoshield, R, A; Ariya, R, A; Ariya, R, A; Augustine Temperature Management, R; Avedro, R, A; Avellino, R; Avellino, R; Aviana, R; Bausch + Lomb, R, A; Belkin Laser, R, A; Broadspot, R, A; Bruder, R; Checked-Up, R, A; Combangio, Inc., R, A; Confluence Acquisition Partners, Inc., R; CorneaGen, R, A; Crinetcs, R; CXLO, R; E-Vision, R; E-Vision, R; E-Vision Medical Devices, R; E-Vision Photography, R, A; E-Vision Photography, R, A; Egg Basket Ventures, R; Egg Factory, R; Elenza, R; Encore, R; Encore, R; Equinox, R, A; ETON, R; Evolus, R; Excel-Lens, Inc., R; Eye Brain, R; Flying L. Ventures, R, A; ForSight Vision 3, R, A; ForSight Vision 6, R, A; Freedom Software, R; Freedom Software, R; FZioMed, Inc.,, R; G.Nano, R; Glaukos Corp.,, R, A; Gondola, R, A; Harrow Health, R, A; Healthcare Transaction Services, R, A; Healthcare Transaction Services, R, A; Healthe, R, A; Healthe, R, A; High Performance Optics, R; High Performance Optics, R; IanTech, R, A; Iantech, R, A; IDoc, Inc., R; IDoc, Inc., R; iiCayr, (e-commerce), R, A; Imprimis, R, A; Injectsense, R, A; InjectsSense, R, A; Innovega, R; Innovega, R; iVeena, R, A; Kedalion Therapeutics, R, A; LeGrande, R, A; LenSar, R, A; LenSar, R, A; Lentechs, R, A; Lenticular Research Group, R; Lumineyes, R; Minnesota Eye Consultants, R, A; Mynosys, R, A; Mynosys, R, A; Novabay, R, A; Nutritional Holdings, R; Ocular Optics, R, A; Ocular Surgery News, A; Ocular Therapeutix, R, A; Oculatec, R; Omega Ophthalmics, R, A; Omeros Corp, R, A; Omeros Corp, R, A; ORASIS, R, A; Oyster Point, R, A; PogoTec, R; Q Sensei, R; Refractec, R, A; Revital Vision, R; Revital Vision, R; RxSight, R, A; Schroeder Ventures Fund II, III, IV,VI,, R; SightLife Surgical, R, A; SightPath, R; SilkTech, R, A; SilkTech, R, A; Solbeam, Inc.,, R; Strathsprey Crown, R; Stroma, R; SunPharma, A; SunPharma, A; SunPharma, A; Surface Pharma, R, A; Tarsus, R, A; Tarsus, R, A; Tear Film, R, A; Tear Film, R, A; Tear Film, R, A; TearClear, R, A; TearClear, R, A; TearLabs, Inc.,, R, A; TearLabs, Inc.,, R, A; Tissue Tech, R; Tissue Tech, R; Tracey Technologies, R, A; Tracey Technologies, R, A; Tracey Technologies, R, A; True Digital Synergy, R; Versant Fund Side Fund, R; Viradax, R; Visant, R, A; Visant, R, A; Vision Solutions Technology, R, A; Vision Solutions Technology, R, A; Visionary Ventures, R, A; Visionary Ventures, R, A; Visionary Ventures, R, A; Zeiss, A

Cynthia Matossian MD Aerie Pharmaceuticals, A; Alcon, A, B; Allergan, A, B; Bausch + Lomb, A, B; Bruder Healthcare, A; Checked-Up, R, A; Conclusn, A; Dompe, A, D; EyePoint, A, B; EyeVance, A, B; Guardion Health Services, A, B; Imprimis Pharmaceuticals, A, B, D; Johnson & Johnson, A, B, D; Kala Pharmaceuticals, A, B; Lacriscience, A, B; Lenstec, A; Lumenis, A, B; Macro, A; MDBackline, A; Novartis, A, B, D; Novartis, A, B, D; NuSight Medical, A, B; Ocular Science, A; Ocular Therapeutix, Inc, A, D; Olympic, A, B; Omeros, A, B; Physician Recommended Nutriceuticals, R, A, B; Quidel, A; Strathspey Crown, R; Sun Pharmaceuticals, A, B; TearLab, A, B; TearScience (J&J), A, B; TissueTech, A, B; Veterinarian Recommended Solutions, R; Zeiss, A, B

Audrey Tally Rostov, MD Alcon, A; Allergan, B; Avedro, A, B; Bausch and Lomb, A, B; CorneaGen, B; Eyevance, A; Kala, A, B; SUN, A, B; Zeiss, A

Julie Schallhorn, MD Zeiss, A

Neal Shorstein, MD No Relevant Financial Interests

George Waring IV, MD Alcon Laboratories, Inc, A; Avellino Labs, Inc, A; Ziemer Ophthalmic Systems, Inc, A

Mitchell Weikert, MD Alcon, A; Allergan, A; B&L, A, B, E; Eye Point Pharmaceutical, A, B; Health-e, R; J&J Vision, A; LENSAR, A; Ocular Therapeutix, A; Omeros, A, B; Pogotec, R; Presby Therapies, R; RPS, R; RxSight, R; Sun Pharmaceutical, B; Tissuetech, R; UBeam, R; Zeiss, A

Module 8

Surendra Basti, MD Bausch, A; Johnson and Johnson, A

Marjan Farid, MD Allergan, A; Biotissue, A; CorneaGen, A; Dompe, A; Eyepoint, B; Johnson and Johnson vision, A; KALA, A; Novartis, A

Bonnie Henderson, MD Alcon, A, B; Eyepoint, A; Kala, A; Novartis, A, B; Zeiss, A

Sumitra Khandelwal, MD Alcon, A; allergan, A; Avellino, A; Bausch & Lomb, A; Dompe, A; Eyevance, A; Kala, A; Ocular Therapeutix, A; Omeros, A; Shire, A; Zeiss, A

Florian Kretz, MD ACUFOCUS, A, B, C, D, E; AVS, A, B, C, D, E; Bausch & Lomb, B; Biotech, A, B, C, D, E; Carl Zeiss Meditech, A, B, C, D, E; Glaukos, B; Hanita, A, B, C; Hoya, D; iSTAAR, D; Johnson & Johnson, D; MST, B; Mynosis, A, C; Nidek, B, E; Oculentis, A, B, C, D, E; Optopol, D; PhysIOL, D, E; Polytech, B; Rayner, D; Santen, A, B, C, D, E; Teleon, A, B, C, D, E; VOG, B; VSY, A, B, C, D, E

Kevin Miller, MD Alcon Laboratorues, A, D; Johnson & Johnson Vision, A; Zeiss, A

Roberto Pineda, MD Amgen, A; Elseiver, P; HealthyMee, R; Sanofi Fenzyme, A

Naveen Rao, MD Parexel, A; W.L. Gore, A

Tal Raviv, MD Bayer, S; Glaukos, B; Ivantis, A; Johnson & Johnson Vision, A, B; Lumenis, B; Ocular Therapeutix, A, B

Blake WIlliamson, MD Bausch and Lomb, B, D; Glaukos, B, D; Johnson and Johnson, B, D; New world medical, B, D; Sight sciences, B, D

Module 9

Gerd Auffarth, MD AcuFocus, D; Alcon, A, B, D, E; Alimera, B, D, E; Anew, D; Bausch & Lomb, B, E; Biotech, B, D; Carl Zeiss, B, D, E; Contamac, D; Glaukos, B, D; Hoya, B, D, E; J&J, A, B, D, E; Kowa, B, D, E; Oculentis, B, D, E; Oculus, B, D; Physiol, D; Presbiy, A, B, E; Rayner, B, D, E; Santen, B, D, E; SIFI, B, D, E; Ursapharm, B, D, E

Francesco Carones, MD Alcon, A; CSO, A; Hoya, A; Johnson & Johnson Vision, A; Percept Corp., R; Slack Inc., A; Vivior, A; WaveLight, A; Zeiss, A

Huck Holz, MD No Relevant Financial Interests

Nick Mamalis, MD Advanced Vision Science, D; Alcon, D; Anew Optics, A, D; Atia Vision, D; ClarVista Medical, D; Clearsight, D; CoDa Theraputics, D; cord, D; Genisphere, D; Hoya, D; KeraMed Polymeditech, D; LensGen, D; Medicontur, D; Merck, D; Mynosys, D; Omega, D; PerfectLens, A, D; PhysIOL, D; Powervision, D; QURA, Inc, D; Zeiss, D

Sheri Rowen, MD Alcon, A, B; Allergan, A, B; Bausch & Lomb, A, B; Novartis, A, B

Liliana Werner, MD Alcon, A, D; Atia, D; Bausch & Lomb, A, D; ClearSight, D; Hoya, A, D; LensGen, D; Merck, D; Millennium Biomedical, D; PerfectLens, D; PhysIOL, D; Powervision, A, D; Qura, D; Refocus, D; SpyGlass Ophthalmics, D; Zeiss, D

Roger Zaldivar, MD ACUFOCUS, A, E; Johnson & Johnson, A; OCULENTIS, A; PHYSIOL, E; ZEISS, A